Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan; rampril; or both:(ONTARGET/TRANSCEND)Trials

: Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P, Mann JF, Diaz R, Dagenais GR, Jennings GL, Liu L, Jansky P, Yusuf S, ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators, Kantola I

: 2010

: Circulation

: 12

: 121

: 12

: 1439

: 1446

: 8

: 0009-7322

DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.864199